MIRA INFORM REPORT

 

 

Report Date :

01.08.2014

 

IDENTIFICATION DETAILS

 

Name :

UNIBIOS INTERNATIONAL CO., LTD.

 

 

Registered Office :

No.271, Sec.3, Minzu Rd., West District, Tainan City 703

 

 

Country :

Taiwan

 

 

Date of Incorporation :

10.09.2003

 

 

Com. Reg. No.:

80481487

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

subject is engaged in trading of medicines and health care products from public files according to the supplied name

 

 

No of Employees :

Not Available 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown 

 

 

Litigation :

Clear 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 01, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

Taiwan

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


                                                           Taiwan ECONOMIC OVERVIEW

 

Taiwan has a dynamic capitalist economy with gradually decreasing government guidance of investment and foreign trade. Exports, led by electronics, machinery, and petrochemicals have provided the primary impetus for economic development. This heavy dependence on exports exposes the economy to fluctuations in world demand. Taiwan's diplomatic isolation, low birth rate, and rapidly aging population are other major long-term challenges. Free trade agreements have proliferated in East Asia over the past several years, and following the landmark Economic Cooperation Framework Agreement (ECFA) signed with China in June 2010, Taiwan in July 2013 signed a free trade deal with New Zealand—Taipei’s first-ever with a country with which it does not maintain diplomatic relations—and in November inked a trade pact with Singapore. Negotiations continue on follow-on components of ECFA regarding trade in goods and a dispute resolution mechanism; a trade in services agreement is under review in the legislature. Taiwan's Total Fertility rate of just over one child per woman is among the lowest in the world, raising the prospect of future labor shortages, falling domestic demand, and declining tax sales. Taiwan's population is aging quickly, with the number of people over 65 accounting for 11.2% of the island's total population as of 2012. The island runs a large overall trade surplus largely because of its surplus with China, and its foreign reserves are the world's sixth largest, behind China, Japan, Saudi Arabia, Russia, and Switzerland. In 2006 China overtook the US to become Taiwan's second-largest source of imports after Japan. China is also the island's number one destination for foreign direct investment. Taiwan since 2009 has gradually loosened rules governing Chinese investment on the island, and has also secured greater market access for its investors in the mainland. In August 2012, Taiwan Central Bank signed a memorandum of understanding on cross-Strait currency settlement with its Chinese counterpart. The MOU allows for the direct settlement of Chinese RMB and the New Taiwan dollar across the Strait, which could help develop Taiwan into a local RMB hub. Closer economic links with the mainland bring greater opportunities for the Taiwan economy, but also poses new challenges as the island becomes more economically dependent on China while political differences remain unresolved.

 

Source : CIA


Contact Points

 

Company Name:

Unibios International Co., Ltd.

Supplied Name:

Unibios Int'l Co Ltd

Supplied Address:

158 Min Chuan Rd Section 3 Central Dist Tainan City 700xxx

 

Notes: The exact name is as above. Since we didn’t find subject, the trading address is not available from any sources.

 

Credit Summary

 

Credit Opinion:

Since we did not contact the subject and the operation information is not confirmed, caution should be exercised.

 

 

Special Note

 

We tried to contact the subject through the supplied number +886-6-221-1737; it says the number is a vacant number.

 

According to the supplied name and address, we cannot find any valid contact information from public files.

 

We found subject is engaged in trading of medicines and health care products from public files according to the supplied name. But the operation is not confirmed by the subject.

 

Update to date of reporting, we failed to get in touch with subject. If you can supply further information such as current telephone number, we’d like to have the investigation resumed.

 

We found subject’s registration information as follows for reference.

 

 

Company Identification Details

 

Registered Name:

Unibios International Co., Ltd.

Registered Address:

No.271, Sec.3, Minzu Rd., West District, Tainan City 703, Taiwan

Date of Foundation:

2003-9-10

Registration Number:

80481487

Registry:

Tainan City Government

Registered Capital:

NTD 5,000,000 (USD 166,500)

(As of 2014.08, 1 NTD = 0.0333 USD)

Legal Representatives:

Shuhua Guo

Legal Form:

Private Limited Liability Company

Staff:

N/A

Listed at Stock Exchange:

No

Date of Last Annual Return:

2013-12-23

 

Notes: Since we didn’t find subject, the staff number is not available from any sources.

 

 

History

 

Subject was incorporated on 2003-9-10 with registered number 80481487 as Private Limited Liability Company in Taiwan.

 

 

Corporate Structure

 

Subject did not register any subsidiaries or branches; from other source we could not obtain the relevant information, either.

 

 

Shareholders

 

Major Shareholders

(Unit: NTD)

Name

Subscription Amount

Shuhua Guo

100,000

 

 

Management Information

 

Core Management

Director

Name

Shuhua Guo

Position

Director

 

Operation Information

 

Offices & Factories

We cannot confirm subject current trading address at this stage.

 

Operation Information

l         The registered activities of subject:

Business Code

Details

F401010 

The international trade

F107070 

Veterinary drug wholesaling

F108021 

Western medicine wholesaling

F107020 

Dye pigment wholesaling

F102130 

Spices wholesale

F102160 

Auxiliary food wholesaling

F113010 

Mechanical wholesaling

F102120 

Sugar wholesale

F207020 

Dye paint retail

F208021 

Western medicine retail

F213080 

Mechanical equipment retail

F207070 

Animal drug retailing

ZZ99999 

Besides licensed business, all other business items those are not banned or restricted.

 

We found subject is engaged in trading of medicines and health care products from public files according to the supplied name. But the operation is not confirmed by the subject.

 

Import and export right:

Import right

Yes

Export right

Yes

 

 

Financial Information

 

Subject has no obligations to disclose its financial statements to the third party according to the relevant policy in Taiwan and the only source from which we can obtain the information is the subject itself.

 

Since we didn't get in touch with subject, the relevant information is not available from any sources.

 

 

 

Bankers

 

Subject declined to disclose its bank details; from other source we could not obtain the relevant information, either.

 

 

Public Record

 

Mortgage

No chattel mortgage record of subject has been found within the recent 3 months.

 

Lawsuit

Up to date of reporting, no existing or latent litigation of the subject has been found.

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.25

UK Pound

1

Rs.101.92

Euro

1

Rs.80.70

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

MNL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

--

NB

                                       New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.